The expression of iNOS is increased in the liver of diabetic mice leading to an impairment in insulin signaling and hyperglycemia, while iNOS inhibition (L-NIL) improves insulin signaling (liver) and prevents hyperglycemia (44). The gene discussed is NOS2; the disease is Hyperglycemia.